메뉴 건너뛰기




Volumn 38, Issue 2, 2011, Pages 455-464

Antitumor effect of the vascular-disrupting agent ZD6126 in a murine renal cell carcinoma model

Author keywords

Angiogenesis; Corrosion cast; Murine renal cell carcinoma; Vascular disrupting agents; ZD6126

Indexed keywords

N ACETYLCOLCHINOL PHOSPHATE;

EID: 78651244619     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2010.867     Document Type: Article
Times cited : (4)

References (29)
  • 1
    • 85013312416 scopus 로고
    • Tumor angiogenesis: Therapeutic implications
    • Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
    • (1971) N Engl J Med , vol.285 , pp. 1182-1186
    • Folkman, J.1
  • 2
    • 15544381413 scopus 로고    scopus 로고
    • Receptor tyrosine kinases and anticancer therapy
    • Medinger M and Drevs J: Receptor tyrosine kinases and anticancer therapy. Curr Pharm Des 11: 1139-1149, 2005.
    • (2005) Curr Pharm des , vol.11 , pp. 1139-1149
    • Medinger, M.1    Drevs, J.2
  • 3
    • 0028929803 scopus 로고
    • Angiogenesis in cancer, vascular, rheumatoid and other disease
    • Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995.
    • (1995) Nat Med , vol.1 , pp. 27-31
    • Folkman, J.1
  • 4
    • 0034282515 scopus 로고    scopus 로고
    • Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model
    • Drevs J, Hofmann I, Hugenschmidt H, Wittig C, Madjar H, Muller M, Wood J, Martiny-Baron G, Unger C and Marme D: Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model. Cancer Res 60: 4819-4824, 2000.
    • (2000) Cancer Res , vol.60 , pp. 4819-4824
    • Drevs, J.1    Hofmann, I.2    Hugenschmidt, H.3    Wittig, C.4    Madjar, H.5    Muller, M.6    Wood, J.7    Martiny-Baron, G.8    Unger, C.9    Marme, D.10
  • 5
    • 20044375036 scopus 로고    scopus 로고
    • The VEGF receptor tyrosine kinase inhibitor, ZD6474, inhibits angiogenesis and affects microvascular architecture within an orthotopically implanted renal cell carcinoma
    • Drevs J, Konerding MA, Wolloscheck T, Wedge SR, Ryan AJ, Ogilvie DJ and Esser N: The VEGF receptor tyrosine kinase inhibitor, ZD6474, inhibits angiogenesis and affects microvascular architecture within an orthotopically implanted renal cell carcinoma. Angiogenesis 7: 347-354, 2004.
    • (2004) Angiogenesis , vol.7 , pp. 347-354
    • Drevs, J.1    Konerding, M.A.2    Wolloscheck, T.3    Wedge, S.R.4    Ryan, A.J.5    Ogilvie, D.J.6    Esser, N.7
  • 6
    • 0027197245 scopus 로고
    • Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
    • Kim KJ, Li B, Winer J, Armanini M, Gillett N, Phillips HS and Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362: 841-844, 1993.
    • (1993) Nature , vol.362 , pp. 841-844
    • Kim, K.J.1    Li, B.2    Winer, J.3    Armanini, M.4    Gillett, N.5    Phillips, H.S.6    Ferrara, N.7
  • 7
    • 75149149393 scopus 로고    scopus 로고
    • Antitumor and antiangiogenic activity of cediranib in a preclinical model of renal cell carcinoma
    • Medinger M, Esser N, Zirrgiebel U, Ryan A, Jürgensmeier JM and Drevs J: Antitumor and antiangiogenic activity of cediranib in a preclinical model of renal cell carcinoma. Anticancer Res 29: 5065-5076, 2009.
    • (2009) Anticancer Res , vol.29 , pp. 5065-5076
    • Medinger, M.1    Esser, N.2    Zirrgiebel, U.3    Ryan, A.4    Jürgensmeier, J.M.5    Drevs, J.6
  • 11
    • 0842311621 scopus 로고    scopus 로고
    • Vascular targeting agents as cancer therapeutics
    • Thorpe PE: Vascular targeting agents as cancer therapeutics. Clin Cancer Res 10: 415-427, 2004.
    • (2004) Clin Cancer Res , vol.10 , pp. 415-427
    • Thorpe, P.E.1
  • 15
    • 0036569804 scopus 로고    scopus 로고
    • Enhancement of radiation therapy by the novel vascular targeting agent ZD6126
    • Siemann DW and Rojiani AM: Enhancement of radiation therapy by the novel vascular targeting agent ZD6126. Int J Radiat Oncol Biol Phys 53: 164-171, 2002.
    • (2002) Int J Radiat Oncol Biol Phys , vol.53 , pp. 164-171
    • Siemann, D.W.1    Rojiani, A.M.2
  • 17
    • 33645732100 scopus 로고    scopus 로고
    • Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors
    • Beerepoot LV, Radema SA, Witteveen EO, Thomas T, Wheeler C, Kempin S and Voest EE: Phase I clinical evaluation of weekly administration of the novel vascular-targeting agent, ZD6126, in patients with solid tumors. J Clin Oncol 24: 1491-1498, 2006.
    • (2006) J Clin Oncol , vol.24 , pp. 1491-1498
    • Beerepoot, L.V.1    Radema, S.A.2    Witteveen, E.O.3    Thomas, T.4    Wheeler, C.5    Kempin, S.6    Voest, E.E.7
  • 19
    • 33751078812 scopus 로고    scopus 로고
    • The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumor agents targeting angiogenesis
    • Drevs J and Schneider V: The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumor agents targeting angiogenesis. J Intern Med 260: 517-529, 2006.
    • (2006) J Intern Med , vol.260 , pp. 517-529
    • Drevs, J.1    Schneider, V.2
  • 21
  • 23
    • 0037112419 scopus 로고    scopus 로고
    • High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow
    • Goertz DE, Yu JL, Kerbel RS, Burns PN and Foster FS: High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Res 62: 6371-6375, 2002.
    • (2002) Cancer Res , vol.62 , pp. 6371-6375
    • Goertz, D.E.1    Yu, J.L.2    Kerbel, R.S.3    Burns, P.N.4    Foster, F.S.5
  • 24
    • 0037699955 scopus 로고    scopus 로고
    • Angiogenesis in health and disease
    • Carmeliet P: Angiogenesis in health and disease. Nat Med 9: 653-660, 2003.
    • (2003) Nat Med , vol.9 , pp. 653-660
    • Carmeliet, P.1
  • 25
    • 0036644835 scopus 로고    scopus 로고
    • Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lungadenocarcinoma in nude mice
    • Goto H, Yano S, Zhang H, Matsumori Y, Ogawa H, Blakey DC and Sone S: Activity of a new vascular targeting agent, ZD6126, in pulmonary metastases by human lungadenocarcinoma in nude mice. Cancer Res 62: 3711-3715, 2002.
    • (2002) Cancer Res , vol.62 , pp. 3711-3715
    • Goto, H.1    Yano, S.2    Zhang, H.3    Matsumori, Y.4    Ogawa, H.5    Blakey, D.C.6    Sone, S.7
  • 26
    • 0142155561 scopus 로고    scopus 로고
    • Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response
    • Horsman MR and Murata R: Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response. Int J Radiat Oncol Biol Phys 57: 1047-1055, 2003.
    • (2003) Int J Radiat Oncol Biol Phys , vol.57 , pp. 1047-1055
    • Horsman, M.R.1    Murata, R.2
  • 27
    • 33644876060 scopus 로고    scopus 로고
    • Vascular targeting in pancreatic cancer: The novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models
    • Kleespies A, Köhl G, Friedrich M, Ryan AJ, Barge A, Jauch KW and Bruns CJ: Vascular targeting in pancreatic cancer: the novel tubulin-binding agent ZD6126 reveals antitumor activity in primary and metastatic tumor models. Neoplasia 7: 957-966, 2005.
    • (2005) Neoplasia , vol.7 , pp. 957-966
    • Kleespies, A.1    Köhl, G.2    Friedrich, M.3    Ryan, A.J.4    Barge, A.5    Jauch, K.W.6    Bruns, C.J.7
  • 28
    • 0035906856 scopus 로고    scopus 로고
    • 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon
    • Konerding MA, Fait E and Gaumann A: 3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon. Br J Cancer 84: 1354-1362, 2001.
    • (2001) Br J Cancer , vol.84 , pp. 1354-1362
    • Konerding, M.A.1    Fait, E.2    Gaumann, A.3
  • 29
    • 0032952966 scopus 로고    scopus 로고
    • Evidence for characteristic vascular patterns in solid tumors: Quantitative studies using corrosion casts
    • Konerding MA, Malkusch W, Klapthor B, et al: Evidence for characteristic vascular patterns in solid tumors: quantitative studies using corrosion casts. Br J Cancer 80: 724-732, 1999.
    • (1999) Br J Cancer , vol.80 , pp. 724-732
    • Konerding, M.A.1    Malkusch, W.2    Klapthor, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.